Rohann Correa

1.7k total citations
49 papers, 766 citations indexed

About

Rohann Correa is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rohann Correa has authored 49 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rohann Correa's work include Renal cell carcinoma treatment (13 papers), Advanced Radiotherapy Techniques (10 papers) and Cancer Genomics and Diagnostics (9 papers). Rohann Correa is often cited by papers focused on Renal cell carcinoma treatment (13 papers), Advanced Radiotherapy Techniques (10 papers) and Cancer Genomics and Diagnostics (9 papers). Rohann Correa collaborates with scholars based in Canada, United States and Germany. Rohann Correa's co-authors include Gabriel E. DiMattia, Trevor G. Shepherd, Yudith Ramos Valdés, Alexander V. Louie, David A. Palma, Andrew Warner, Michael Staehler, Bin S. Teh, William Chu and Lee Ponsky and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Rohann Correa

46 papers receiving 762 citations

Peers

Rohann Correa
Chika Nwachukwu United States
Stephanie Yoon United States
Jun Sakakibara‐Konishi Japan
W. Mai United States
X. Zhang United States
Ghassan Allo Canada
Jimmy Pramana Netherlands
Jinbo Yue China
Ichiro Yamasaki Japan
Chang Shu Wang Canada
Chika Nwachukwu United States
Rohann Correa
Citations per year, relative to Rohann Correa Rohann Correa (= 1×) peers Chika Nwachukwu

Countries citing papers authored by Rohann Correa

Since Specialization
Citations

This map shows the geographic impact of Rohann Correa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohann Correa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohann Correa more than expected).

Fields of papers citing papers by Rohann Correa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohann Correa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohann Correa. The network helps show where Rohann Correa may publish in the future.

Co-authorship network of co-authors of Rohann Correa

This figure shows the co-authorship network connecting the top 25 collaborators of Rohann Correa. A scholar is included among the top collaborators of Rohann Correa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohann Correa. Rohann Correa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Shuang, Hyunnam Ryu, J. Proudfoot, et al.. (2025). Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.. Journal of Clinical Oncology. 43(5_suppl). 308–308. 2 indexed citations
2.
Tan, Vivian, Rohann Correa, Timothy K. Nguyen, et al.. (2024). Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes. International Journal of Radiation Oncology*Biology*Physics. 121(1). 39–44. 3 indexed citations
3.
Correa, Rohann, Timothy K. Nguyen, Alexander V. Louie, et al.. (2024). Measuring the Integration of Stereotactic Ablative Radiotherapy plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes. International Journal of Radiation Oncology*Biology*Physics. 120(2). S104–S105.
4.
Sandler, Howard M., Priti Lal, Michael D. Feldman, et al.. (2024). Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens. The Journal of Pathology. 265(2). 146–157. 1 indexed citations
5.
Nguyen, Timothy K., David A. Palma, Mark T. Corkum, et al.. (2024). Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease. International Journal of Radiation Oncology*Biology*Physics. 120(5). 1231–1238. 5 indexed citations
6.
Harding, Thomas H., Lucas C. Mendez, David D’Souza, et al.. (2023). Deep learning‐based ultrasound auto‐segmentation of the prostate with brachytherapy implanted needles. Medical Physics. 51(4). 2665–2677. 4 indexed citations
7.
Barbour, Andrew B., Simon Kirste, Shankar Siva, et al.. (2023). The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma. Cancers. 15(14). 3672–3672. 2 indexed citations
8.
Correa, Rohann, et al.. (2022). Five-Fraction Stereotactic Ablative Radiotherapy to the Pelvis and Prostate with Focal Intra-Prostatic Boost: Outcomes of the 5STAR Trial. International Journal of Radiation Oncology*Biology*Physics. 114(3). S132–S132. 2 indexed citations
9.
Correa, Rohann, Gerard Morton, Hans T. Chung, et al.. (2022). Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?. Radiotherapy and Oncology. 169. 51–56. 7 indexed citations
10.
Correa, Rohann, et al.. (2022). Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care?. Clinical Oncology. 34(5). 318–324. 1 indexed citations
11.
Correa, Rohann, et al.. (2021). A Framework for Assuring the Safety, Training, Evaluation, and Wellness of Radiation Oncology Residents During the COVID-19 Pandemic (ASTEROiD-COVID19). Advances in Radiation Oncology. 6(5). 100754–100754. 2 indexed citations
12.
Siva, Shankar, Rohann Correa, Andrew Warner, et al.. (2020). Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK). International Journal of Radiation Oncology*Biology*Physics. 108(4). 941–949. 51 indexed citations
13.
Correa, Rohann, et al.. (2020). Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease. The Cancer Journal. 26(2). 156–165. 16 indexed citations
14.
15.
Tan, Vivian, Rohann Correa, George Rodrigues, & David A. Palma. (2019). Intraluminal Superior Vena Cava Invasion. Journal of Thoracic Oncology. 15(1). 144–145. 1 indexed citations
16.
17.
Correa, Rohann, Joseph K. Salama, Michael T. Milano, & David A. Palma. (2016). Stereotactic Body Radiotherapy for Oligometastasis. The Cancer Journal. 22(4). 247–256. 35 indexed citations
18.
Correa, Rohann, Yudith Ramos Valdés, Elena N. Fazio, et al.. (2014). Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability. Carcinogenesis. 35(9). 1951–1961. 60 indexed citations
19.
Correa, Rohann, et al.. (2012). BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation. Clinical & Experimental Metastasis. 29(4). 293–313. 24 indexed citations
20.
Correa, Rohann, et al.. (2011). Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis. 33(1). 49–58. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chika Nwachukwu Breakdown of academic impact, for papers by Stephanie Yoon Breakdown of academic impact, for papers by Jun Sakakibara‐Konishi Breakdown of academic impact, for papers by W. Mai Breakdown of academic impact, for papers by X. Zhang Breakdown of academic impact, for papers by Ghassan Allo Breakdown of academic impact, for papers by Jimmy Pramana Breakdown of academic impact, for papers by Jinbo Yue Breakdown of academic impact, for papers by Ichiro Yamasaki Breakdown of academic impact, for papers by Chang Shu Wang
Rankless by CCL
2026